IDMI @ $2.08, last chance to load up. Has approval of MEPACT in EU and under review with FDA. Company worth $6.00+ a share just on projected sales of MEPACT in EU (x3 revs). 28.35M outstanding shares. Palo Alto Investors owns about 40%+ of float. Do your own DD. JMHO. GLTA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.